2002
DOI: 10.1016/s0920-9964(01)00188-8
|View full text |Cite
|
Sign up to set email alerts
|

A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

33
280
4
2

Year Published

2007
2007
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 427 publications
(328 citation statements)
references
References 30 publications
33
280
4
2
Order By: Relevance
“…This decrease appears specific for PV-containing interneurons, which is consistent with the reduction in local inhibitory GABAergic PV neuron staining that has been reported in postmortem studies in human schizophrenia patients (Lewis et al, 2005;Woo et al, 1998;Zhang and Reynolds, 2002). Thus, the reduction in PV interneuron functionality would likely affect the cortical pyramidal neuron output.…”
Section: Modulatory Influence Of Bla On Vhipp-evoked Firing In Mpfc Isupporting
confidence: 85%
“…This decrease appears specific for PV-containing interneurons, which is consistent with the reduction in local inhibitory GABAergic PV neuron staining that has been reported in postmortem studies in human schizophrenia patients (Lewis et al, 2005;Woo et al, 1998;Zhang and Reynolds, 2002). Thus, the reduction in PV interneuron functionality would likely affect the cortical pyramidal neuron output.…”
Section: Modulatory Influence Of Bla On Vhipp-evoked Firing In Mpfc Isupporting
confidence: 85%
“…The original finding consistent with a preferential involvement of CA2 showed profound loss of parvalbumin immunoreactivity (a marker of specific subclasses of interneurons) in this subregion [130], replicated in [131,132], although decreases in parvalbumin immunoreactivity outside the hippocampus are widespread [133]. Relative to other hippocampal subfields, binding assays have shown reduced AMPA [134] and histamine H3 receptor binding [135] in CA2 of patients diagnosed with schizophrenia and bipolar disorder respectively , and together these histological and neurochemical abnormalities may manifest as morphological changes at the structural level [136].…”
Section: Box 4: Ca2 In Diseasementioning
confidence: 62%
“…Our sub-chronic PCP dosing regime causes reduced density of parvalbumin-immunoreactive neurons in hippocampal regions (Abdul-Monim et al, 2007) and levels of brain-derived neurotrophic factor mRNA (BDNF) in cortical regions (Snigdha et al, 2007) in rats. Reductions in GABAergic interneurones in these areas have been found in post-mortem analysis from patients with schizophrenia (Benes et al, 1991;Benes and Berretta, 2001;Beasley et al, 2002;Zhang and Reynolds, 2002). We have shown that atypical but not classical antipsychotics can reverse these cognitive deficits; however, in the clinic there is differing evidence for the efficacy of atypical antipsychotics in improving cognition with the CATIE study (Lieberman, 2006;Keefe et al, 2007) and the UK Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS; Jones et al, 2006; suggesting that antipsychotics actually have a limited effect.…”
Section: Introductionmentioning
confidence: 79%